We are live on
!
Find out more
CP
CenterBook Partners Portfolio holdings
AUM
$2.04B
1-Year Est. Return
35.27%
This Fund
S&P 500
This Quarter
Est. Return
+22.1%
1 Year Est. Return
+35.27%
3 Year Est. Return
+62.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.04B
AUM Growth
+$174M
(+9.4%)
Cap. Flow
-$93.1M
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
906
New
278
Increased
171
Reduced
244
Closed
213
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$29.4M |
| 2 |
Mastercard
MA
|
+$25.5M |
| 3 |
Lumentum
LITE
|
+$21.1M |
| 4 |
SPCX
SpaceX
SPCX
|
+$20.5M |
| 5 |
Palantir
PLTR
|
+$18.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$25.1M |
| 2 |
Advanced Micro Devices
AMD
|
+$22.9M |
| 3 |
Amphenol
APH
|
+$21.3M |
| 4 |
Xometry
XMTR
|
+$19.3M |
| 5 |
MongoDB
MDB
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.3% |
| 2 | Healthcare | 14.79% |
| 3 | Industrials | 13.6% |
| 4 | Communication Services | 10.03% |
| 5 | Financials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
251
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.81M | 0.09% |
+57,723
| New | +$1.7M |
|
252
Dorman Products
DORM
$3.76B
| $1.81M | 0.09% |
13,251
-42,548
| -76% | -$5.04M |
|
|
CMPS
253
Compass Pathways
CMPS
$2.01B
| $1.78M | 0.09% |
125,594
-283,643
| -69% | -$2.88M |
|
254
Ball Corp
BALL
$15.9B
| $1.77M | 0.09% |
+28,444
| New | +$1.67M |
|
255
Wendy's
WEN
$1.45B
| $1.76M | 0.09% |
+212,771
| New | +$1.52M |
|
256
AirSculpt Technologies
AIRS
$174M
| $1.76M | 0.09% |
+391,812
| New | +$1.59M |
|
257
XPEL
XPEL
$1.3B
| $1.76M | 0.09% |
+35,387
| New | +$1.61M |
|
258
Dow Inc
DOW
$20.9B
| $1.75M | 0.09% |
64,092
+57,235
| +835% | +$2.08M |
|
259
Acadia Pharmaceuticals
ACAD
$4.74B
| $1.74M | 0.09% |
68,928
+49,192
| +249% | +$1.08M |
|
260
Royalty Pharma
RPRX
$26.3B
| $1.74M | 0.09% |
31,095
-126,082
| -80% | -$6.56M |
|
261
PROG Holdings
PRG
$1.49B
| $1.73M | 0.08% |
37,066
-39,487
| -52% | -$1.38M |
|
|
JBTM
262
JBT Marel
JBTM
$5.93B
| $1.71M | 0.08% |
+11,775
| New | +$1.52M |
|
263
Primerica
PRI
$9.09B
| $1.7M | 0.08% |
5,988
+3,730
| +165% | +$1.02M |
|
264
Morgan Stanley
MS
$324B
| $1.7M | 0.08% |
8,123
+5,977
| +279% | +$1.18M |
|
265
Ingevity
NGVT
$2.39B
| $1.69M | 0.08% |
22,655
-5,231
| -19% | -$377K |
|
266
AMN Healthcare
AMN
$1.29B
| $1.62M | 0.08% |
50,154
-465,500
| -90% | -$12M |
|
267
Qualcomm
QCOM
$192B
| $1.62M | 0.08% |
+8,773
| New | +$1.64M |
|
268
Mettler-Toledo International
MTD
$25.9B
| $1.62M | 0.08% |
+1,269
| New | +$1.53M |
|
269
Arrowhead Research
ARWR
$11.4B
| $1.61M | 0.08% |
+19,728
| New | +$1.46M |
|
270
DexCom
DXCM
$31.3B
| $1.6M | 0.08% |
+23,799
| New | +$1.59M |
|
271
Arcutis Biotherapeutics
ARQT
$3.05B
| $1.6M | 0.08% |
+60,943
| New | +$1.42M |
|
272
Huntington Ingalls Industries
HII
$11B
| $1.59M | 0.08% |
+5,670
| New | +$1.89M |
|
273
Enphase Energy
ENPH
$4.84B
| $1.58M | 0.08% |
32,146
-150,028
| -82% | -$6.83M |
|
274
Baker Hughes
BKR
$56.4B
| $1.58M | 0.08% |
+28,471
| New | +$1.8M |
|
275
KLA
KLAC
$221B
| $1.58M | 0.08% |
5,232
-36,228
| -87% | -$7.19M |
|
Similar funds
SFI
6CM
UF
C
WCMNY
WPC
BOH
EF
CenterBook Partners's Q2 2026 Portfolio in Review
As of Q2 2026, CenterBook Partners held 906 positions worth $2.04B, up 9.4% from $1.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
CenterBook Partners withdrew a net $93.1M in Q2 2026, closing 213 positions and reducing 244 holdings. Its most notable exit was Home Depot, an estimated $13.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, CenterBook Partners opened a new position in Mastercard worth $26.3M.
- CenterBook Partners's largest Q2 2026 buy was Mastercard: 51,161 shares worth $26.3M.
- CenterBook Partners added most to Netflix in Q2 2026, an estimated $29.4M increase.
- CenterBook Partners's biggest Q2 2026 reduction was Applied Materials, cutting an estimated $25.1M.
- CenterBook Partners fully exited Home Depot in Q2 2026, selling an estimated $13.4M.
- CenterBook Partners's ten largest holdings make up 18% of its $2.04B portfolio in Q2 2026.
- CenterBook Partners opened 278 new positions and closed 213 in Q2 2026.
- CenterBook Partners's portfolio value rose 9.4% quarter-over-quarter to $2.04B.
Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.